The National Science Foundation (NSF) Engineering program (CFDA 47.041) has awarded a $599,918 Project Grant to the Massachusetts Institute of Technology (MIT) to develop a novel non-surgical bioelectronic brain implant for targeted neural stimulation. This paradigm-shifting technology aims to eliminate the need for invasive surgery by enabling self-implantation of ultra-small bioelectronic devices that can circulate through the vasculature and implant in target brain regions. The proposed innovation promises safer, more accessible, and precisely targeted interventions for neurological disorders and neuroscience research compared to existing brain stimulation technologies. This 5-year grant will fund research and development across diverse fields, including applied physics, electrical and bioengineering, and synthetic biology, to realize the first non-surgical brain implant for neuromodulation. If successful, this technology could have vast applications beyond the brain, such as in cardiac pacing, peripheral nerve stimulation, and regenerative medicine.
Generated 3/4/25, 7:16 AM